Q0ST14 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeignja3ho7hswycsfeehzofw726o2njp3ojanrbu44l3apke7sszpy/metadata.json
IPFS of structure file: 
bafybeih4rijg6ofbhg5ydc4hkpdfjaa27ywqtlktmagexztgw2g7bqvbau/AF-Q0ST14-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xF34A7d55E2e42B6a180A8342155823DB363Bd7A5
First NFT owner address (bech32): 
genesis17d98640zus4k5xq2sdpp2kprmvmrh4a9y0msq3
Current NFT ID #166557 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166557
Accession (UniProt):
Q0ST14
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM PERFRINGENS (STRAIN SM101 / TYPE A)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q0ST14 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q0ST14|HEM1_CLOPS Glutamyl-tRNA reductase OS=Clostridium perfringens (strain SM101 / Type A) OX=289380 GN=hemA PE=3 SV=1 MIGVIGVKRNVDIAIREKLALYPKKHKKYVGELLNSFKEVVILNTCNRTEIYFNCTEEISEDEIFDKIFNVFNWNDDLKKYMFLSKEKRAVTHLMEVICGFHSRILGEDQILGQIKDAYKTAISDNSISSELQKMFEIAIACGKKFKTKCKMFEVPVSSVSISINSALLKGCRKFMVLGYGEIGKLAIKHLLSHKVECIYLIVRDKSKASDLEGEIVEILDFNEKNHVINEVDCIVSCTAAPHTVVRNEDIKTEGDIIHIYDLAVPRDVDKELSEKERVILKDIDEISKIDDKNKKIRKERMEEYKHIVEESIEEFLNWLKIREVSSKIRNIKIRENEICSERIKTFSNKGNGENAKLAERMIKSTADAYVNRAIELLKSEALKGSDSSCAEIIEKIFLT